- Home
- VATE vs LUNG Comparison
VATE vs LUNG Comparison
Compare VATE & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VATE
- LUNG
- Stock Information
- Founded
- VATE 1994
- LUNG 1995
- Country
- VATE United States
- LUNG United States
- Employees
- VATE N/A
- LUNG N/A
- Industry
- VATE Metal Fabrications
- LUNG Industrial Specialties
- Sector
- VATE Industrials
- LUNG Health Care
- Exchange
- VATE Nasdaq
- LUNG Nasdaq
- Market Cap
- VATE 70.3M
- LUNG 63.6M
- IPO Year
- VATE 1996
- LUNG 2020
- Fundamental
- Price
- VATE $5.06
- LUNG $1.41
- Analyst Decision
- VATE
- LUNG Buy
- Analyst Count
- VATE 0
- LUNG 7
- Target Price
- VATE N/A
- LUNG $6.81
- AVG Volume (30 Days)
- VATE 41.3K
- LUNG 7.0M
- Earning Date
- VATE 11-12-2025
- LUNG 11-12-2025
- Dividend Yield
- VATE N/A
- LUNG N/A
- EPS Growth
- VATE N/A
- LUNG N/A
- EPS
- VATE N/A
- LUNG N/A
- Revenue
- VATE $1,099,900,000.00
- LUNG $91,664,000.00
- Revenue This Year
- VATE N/A
- LUNG $10.41
- Revenue Next Year
- VATE N/A
- LUNG $10.98
- P/E Ratio
- VATE N/A
- LUNG N/A
- Revenue Growth
- VATE N/A
- LUNG 15.59
- 52 Week Low
- VATE $3.81
- LUNG $1.35
- 52 Week High
- VATE $13.79
- LUNG $9.37
- Technical
- Relative Strength Index (RSI)
- VATE 47.38
- LUNG 39.77
- Support Level
- VATE $4.70
- LUNG $1.65
- Resistance Level
- VATE $5.89
- LUNG $2.11
- Average True Range (ATR)
- VATE 0.39
- LUNG 0.17
- MACD
- VATE -0.08
- LUNG -0.05
- Stochastic Oscillator
- VATE 33.88
- LUNG 7.24
About VATE INNOVATE Corp.
Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.